ANI Pharmaceuticals Inc. (ANIP)
68.74
0.62 (0.91%)
At close: Apr 14, 2025, 3:59 PM
70.00
1.83%
After-hours: Apr 14, 2025, 06:11 PM EDT
0.91% (1D)
| Bid | 65 |
| Market Cap | 1.48B |
| Revenue (ttm) | 614.38M |
| Net Income (ttm) | -18.52M |
| EPS (ttm) | -1.04 |
| PE Ratio (ttm) | -66.1 |
| Forward PE | 10.64 |
| Analyst | Buy |
| Ask | 70 |
| Volume | 193,918 |
| Avg. Volume (20D) | 305,003 |
| Open | 69.61 |
| Previous Close | 68.12 |
| Day's Range | 67.05 - 69.11 |
| 52-Week Range | 52.50 - 70.00 |
| Beta | 0.49 |
About ANIP
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development a...
Full Company ProfileAnalyst Forecast
According to 8 analyst ratings, the average rating for ANIP stock is "Buy." The 12-month stock price forecast is $83, which is an increase of 20.74% from the latest price.
Stock ForecastsNext Earnings Release
ANI Pharmaceuticals Inc. is scheduled to release its earnings on May 9, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+13.39%
ANI Pharmaceuticals shares are trading higher afte...
Unlock content with
Pro Subscription
8 months ago
-9.92%
ANI Pharmaceuticals shares are trading lower after the company announced intent for a $250 million private offering of convertible senior notes.
